The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
TGFβ: the molecular Jekyll and Hyde of cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Generation of a functional mammary gland from a single stem cell
Shackleton, M., Vaillant, F., Simpson, K. J., Stingl, J., Smyth, G. K., Asselin-Labat, M.-L., Wu, L., Lindeman, G. J., & Visvader, J. E. (2006) · Nature · doi:10.1038/nature04372 · Cited by 2,005
Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,995
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
Massagué, J. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043051 · Cited by 1,899
SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
Feng, X.-H., & Derynck, R. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.022404.142018 · Cited by 1,869
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,634
Guy, C. T., Cardiff, R. D., & Muller, W. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.954 · Cited by 1,631
Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer
Siegel, P. M., & Massagué, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1208 · Cited by 1,604
TGFβ signals through a heteromeric protein kinase receptor complex
Wrana, J. L., Attisano, L., Cárcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.-F., & Massague, J. (1992) · Cell · doi:10.1016/0092-8674(92)90395-s · Cited by 1,526
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., & Moses, H. L. (2004) · Science · doi:10.1126/science.1090922 · Cited by 1,401
Self-citationTGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
Thomas, D. A., & Massagué, J. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.012 · Cited by 1,355
Identification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction
Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., & Matsumoto, K. (1995) · Science · doi:10.1126/science.270.5244.2008 · Cited by 1,343
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., et al. (1996) · Science · doi:10.1126/science.274.5291.1363 · Cited by 1,249
Guy, C. T., Webster, M. A., Schaller, M., Parsons, T. J., Cardiff, R. D., & Muller, W. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10578 · Cited by 1,193
Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo
Crawford, S. E., Stellmach, V., Murphy-Ullrich, J. E., Ribeiro, S. M. F., Lawler, J., Hynes, R. O., Boivin, G. P., & Bouck, N. (1998) · Cell · doi:10.1016/s0092-8674(00)81460-9 · Cited by 1,174
Diversity, topographic differentiation, and positional memory in human fibroblasts
Chang, H. Y., Chi, J.-T., Dudoit, S., Bondre, C., van de Rijn, M., Botstein, D., & Brown, P. O. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162488599 · Cited by 1,151
Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase
Lin, H. Y., Wang, X.-F., Ng-Eaton, E., Weinberg, R. A., & Lodish, H. F. (1992) · Cell · doi:10.1016/0092-8674(92)90152-3 · Cited by 1,057
Bhowmick, N. A., Ghiassi, M., Bakin, A., Aakre, M., Lundquist, C. A., Engel, M. E., Arteaga, C. L., & Moses, H. L. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.1.27 · Cited by 1,004
Self-citationGorelik, L., & Flavell, R. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80170-3 · Cited by 962
Moustakas, A., & Heldin, C.-H. (2005) · Journal of Cell Science · doi:10.1242/jcs.02554 · Cited by 958
Miettinen, P. J., Ebner, R., Lopez, A. R., & Derynck, R. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.6.2021 · Cited by 937
Regulation of the Polarity Protein Par6 by TGFß Receptors Controls Epithelial Cell Plasticity
Ozdamar, B., Bose, R., Barrios-Rodiles, M., Wang, H.-R., Zhang, Y., & Wrana, J. L. (2005) · Science · doi:10.1126/science.1105718 · Cited by 881
Transforming growth factor-β in T-cell biology
Gorelik, L., & Flavell, R. A. (2002) · Nature Reviews Immunology · doi:10.1038/nri704 · Cited by 792
Gorelik, L., & Flavell, R. A. (2001) · Nature Medicine · doi:10.1038/nm1001-1118 · Cited by 770
TGF- β signaling in cancer – a double-edged sword
Akhurst, R. J., & Derynck, R. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02130-4 · Cited by 756
High-Throughput Mapping of a Dynamic Signaling Network in Mammalian Cells
Barrios-Rodiles, M., Brown, K. R., Ozdamar, B., Bose, R., Liu, Z., Donovan, R. S., Shinjo, F., Liu, Y., Dembowy, J., Taylor, I. W., et al. (2005) · Science · doi:10.1126/science.1105776 · Cited by 725
Activin Receptor-like Kinase (ALK)1 Is an Antagonistic Mediator of Lateral TGFβ/ALK5 Signaling
Goumans, M.-J., Valdimarsdottir, G., Itoh, S., Lebrin, F., Larsson, J., Mummery, C., Karlsson, S., & ten Dijke, P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00386-1 · Cited by 689
Expression cloning and characterization of the TGF-β type III receptor
Wang, X.-F., Lin, H. Y., Ng-Eaton, E., Downward, J., Lodish, H. F., & Weinberg, R. A. (1991) · Cell · doi:10.1016/0092-8674(91)90074-9 · Cited by 637
Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., & Akhurst, R. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80127-0 · Cited by 628
TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis
Oft, M., Heider, K.-H., & Beug, H. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00533-7 · Cited by 623
TAB1: An Activator of the TAK1 MAPKKK in TGF-β Signal Transduction
Shibuya, H., Yamaguchi, K., Shirakabe, K., Tonegawa, A., Gotoh, Y., Ueno, N., Irie, K., Nishida, E., & Matsumoto, K. (1996) · Science · doi:10.1126/science.272.5265.1179 · Cited by 587
Development of TGF-β signalling inhibitors for cancer therapy
Yingling, J. M., Blanchard, K. L., & Sawyer, J. S. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1580 · Cited by 549
Alterations in components of the TGF-β superfamily signaling pathways in human cancer
LEVY, L., & HILL, C. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.009 · Cited by 539
Barcellos‐Hoff, M. H., & Ravani, S. A. (2000) · PubMed · Cited by 536
TGF-? receptor function in the endothelium
LEBRIN, F., DECKERS, M., BERTOLINO, P., & TENDIJKE, P. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.10.036 · Cited by 513
Information networks in the mammary gland
Hennighausen, L., & Robinson, G. W. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1714 · Cited by 506
The significance of unstable chromosomes in colorectal cancer
Rajagopalan, H., Nowak, M. A., Vogelstein, B., & Lengauer, C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1165 · Cited by 502
BIERIE, B., & MOSES, H. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.006 · Cited by 477
Self-citationDevelopment of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice
Matsui, Y., Halter, S. A., Holt, J. T., Hogan, B. L. M., & Coffey, R. J. (1990) · Cell · doi:10.1016/0092-8674(90)90077-r · Cited by 440
Siegel, P. M., Shu, W., Cardiff, R. D., Muller, W. J., & Massagué, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932636100 · Cited by 429
CD4+CD25+ T Regulatory Cells Suppress NK Cell-Mediated Immunotherapy of Cancer
Smyth, M. J., Teng, M. W. L., Swann, J., Kyparissoudis, K., Godfrey, D. I., & Hayakawa, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1582 · Cited by 420
Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases
Muraoka, R. S., Dumont, N., Ritter, C. A., Dugger, T. C., Brantley, D. M., Chen, J., Easterly, E., Roebuck, L. R., Ryan, S., Gotwals, P. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215234 · Cited by 415
DaCosta Byfield, S., Major, C., Laping, N. J., & Roberts, A. B. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.744 · Cited by 414
Uhl, M., Aulwurm, S., Wischhusen, J., Weiler, M., Ma, J. Y., Almirez, R., Mangadu, R., Liu, Y.-W., Platten, M., Herrlinger, U., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1013 · Cited by 414
Yang, Y.-A., Dukhanina, O., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215333 · Cited by 404
Yang, Y.-A., Dukhanina, O. I., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15333 · Cited by 404
TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression
Tang, B., Vu, M., Booker, T., Santner, S. J., Miller, F. R., Anver, M. R., & Wakefield, L. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318899 · Cited by 393
Wahl, S. M., Hunt, D. A., Wong, H. L., Dougherty, S., McCartney-Francis, N., Wahl, L. M., Ellingsworth, L., Schmidt, J. A., Hall, G., Roberts, A. B., et al. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.9.3026 · Cited by 389
BOGDAN, C., & NATHAN, C. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb35934.x · Cited by 384
Regulation of the Proinflammatory Effects of Fas Ligand (CD95L)
Chen, J.-J., Sun, Y., & Nabel, G. J. (1998) · Science · doi:10.1126/science.282.5394.1714 · Cited by 383
Deckers, M., van Dinther, M., Buijs, J., Que, I., Löwik, C., van der Pluijm, G., & ten Dijke, P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3560 · Cited by 371
Arteaga, C. L., Hurd, S. D., Winnier, A. R., Johnson, M. D., Fendly, B. M., & Forbes, J. T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116871 · Cited by 359
Genomic instability and colon cancer
Grady, W. M. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025861527711 · Cited by 353
TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation
Perlman, R., Schiemann, W. P., Brooks, M. W., Lodish, H. F., & Weinberg, R. A. (2001) · Nature Cell Biology · doi:10.1038/35087019 · Cited by 349
Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
Hayward, S. W., Wang, Y. Z., Cao, M., Hom, Y. K., Zhang, B., Grossfeld, G. D., Sudilovsky, D., & Cunha, G. R. (2001) · PubMed · Cited by 345
Tojo, M., Hamashima, Y., Hanyu, A., Kajimoto, T., Saitoh, M., Miyazono, K., Node, M., & Imamura, T. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00103.x · Cited by 339
Controlling the Angiogenic Switch
Goumans, M.-J., Lebrin, F., & Valdimarsdottir, G. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(03)00142-7 · Cited by 338
Fakhrai, H., Dorigo, O., Shawler, D. L., Lin, H., Mercola, D., Black, K. L., Royston, I., & Sobol, R. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2909 · Cited by 334
McDonald, P. P., Fadok, V. A., Bratton, D. L., & Henson, P. M. (1999) · PubMed · Cited by 332
Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis
Hill, R., Song, Y., Cardiff, R. D., & Van Dyke, T. (2005) · Cell · doi:10.1016/j.cell.2005.09.030 · Cited by 324
Cytoplasmic PML function in TGF-β signalling
Lin, H.-K., Bergmann, S., & Pandolfi, P. P. (2004) · Nature · doi:10.1038/nature02783 · Cited by 312
Dasch, J. R., Pace, D. R., Waegell, W., Inenaga, D., & Ellingsworth, L. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.5.1536 · Cited by 293
Mammary tumor suppression by transforming growth factor beta 1 transgene expression.
Pierce, D. F., Gorska, A. E., Chytil, A., Meise, K. S., Page, D. L., Coffey, R. J., & Moses, H. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4254 · Cited by 291
Self-citationMcDonald, P. P., Fadok, V. A., Bratton, D., & Henson, P. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6164 · Cited by 290
Cheng, N., Bhowmick, N. A., Chytil, A., Gorksa, A. E., Brown, K. A., Muraoka, R., Arteaga, C. L., Neilson, E. G., Hayward, S. W., & Moses, H. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208685 · Cited by 267
Self-citationPierce, D. F., Johnson, M. D., Matsui, Y., Robinson, S. D., Gold, L. I., Purchio, A. F., Daniel, C. W., Hogan, B. L., & Moses, H. L. (1993) · Genes & Development · doi:10.1101/gad.7.12a.2308 · Cited by 264
Self-citationLevéen, P., Larsson, J., Ehinger, M., Cilio, C. M., Sundler, M., Sjöstrand, L. J., Holmdahl, R., & Karlsson, S. (2002) · Blood · doi:10.1182/blood.v100.2.560 · Cited by 259
Forrester, E., Chytil, A., Bierie, B., Aakre, M., Gorska, A. E., Sharif-Afshar, A.-R., Muller, W. J., & Moses, H. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3272 · Cited by 249
Self-citationXiao, Y. Q., Malcolm, K., Worthen, G. S., Gardai, S., Schiemann, W. P., Fadok, V. A., Bratton, D. L., & Henson, P. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111718200 · Cited by 245
Role of transforming growth factor beta in cancer
Pasche, B. (2001) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200002)186:2<153::aid-jcp1016>3.0.co;2-j · Cited by 235
Type I Transforming Growth Factor β Receptor Binds to and Activates Phosphatidylinositol 3-Kinase
Yi, J. Y., Shin, I., & Arteaga, C. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413223200 · Cited by 228
Ahmadzadeh, M., & Rosenberg, S. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5215 · Cited by 225
Han, G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24399 · Cited by 224
Jhappan, C., Geiser, A. G., Kordon, E. C., Bagheri, D., Hennighausen, L., Roberts, A. B., Smith, G. H., & Merlino, G. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05832.x · Cited by 224
TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G1 arrest
Petritsch, C., Beug, H., Balmain, A., & Oft, M. (2000) · Genes & Development · doi:10.1101/gad.854200 · Cited by 223
Activation of p21ras by transforming growth factor beta in epithelial cells.
Mulder, K. M., & Morris, S. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42722-6 · Cited by 223
Reibman, J., Meixler, S., Lee, T. C., Gold, L. I., Cronstein, B. N., Haines, K. A., Kolasinski, S. L., & Weissmann, G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6805 · Cited by 221
TGF-β: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression
Chen, W., & Wahl, S. M. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00003-0 · Cited by 210
Boulanger, C. A., Wagner, K.-U., & Smith, G. H. (2005) · Oncogene · doi:10.1038/sj.onc.1208185 · Cited by 197
Targeted tumor therapy with the TGF-β2 antisense compound AP 12009
SCHLINGENSIEPEN, K., SCHLINGENSIEPEN, R., STEINBRECHER, A., HAU, P., BOGDAHN, U., FISCHERBLASS, B., & JACHIMCZAK, P. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.002 · Cited by 195
Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent.
Cordeiro, M. F., GAY, J. A., & Khaw, P. T. (1999) · PubMed · Cited by 192
Muraoka, R. S., Koh, Y., Roebuck, L. R., Sanders, M. E., Brantley-Sieders, D., Gorska, A. E., Moses, H. L., & Arteaga, C. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8691-8703.2003 · Cited by 191
Self-citationMolecular mechanisms of inactivation of TGF-β receptors during carcinogenesis
Kim, S.-J., Im, Y.-H., Markowitz, S. D., & Bang, Y.-J. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00039-8 · Cited by 188
A role for MEK kinase 1 in TGF- /activin-induced epithelium movement and embryonic eyelid closure
Zhang, L. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg440 · Cited by 182
Moustakas, A., Lin, H. Y., Henis, Y. I., Plamondon, J., O'Connor-McCourt, M. D., & Lodish, H. F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41509-8 · Cited by 181
Kordon, E. C., McKnight, R. A., Jhappan, C., Hennighausen, L., Merlino, G., & Smith, G. H. (1995) · Developmental Biology · doi:10.1006/dbio.1995.1060 · Cited by 180
Geiser, A. G., Letterio, J. J., Kulkarni, A. B., Karlsson, S., Roberts, A. B., & Sporn, M. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.9944 · Cited by 179
Transforming growth factor β 3 induces cell death during the first stage of mammary gland involution
Nguyen, A. V., & Pollard, J. W. (2000) · Development · doi:10.1242/dev.127.14.3107 · Cited by 179
Lee, Y. J., Han, Y., Lu, H. T., Nguyen, V, Qin, H., Howe, P. H., Hocevar, B. A., Boss, J. M., Ransohoff, R. M., & Benveniste, E. N. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2065 · Cited by 177
Cosgrove, D., Rodgers, K., Meehan, D., Miller, C., Bovard, K., Gilroy, A., Gardner, H., Kotelianski, V., Gotwals, P., Amatucci, A., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64802-x · Cited by 176
TGF-β: the perpetrator of immune suppression by regulatory T cells and suicidal T cells
Wahl, S. M., Swisher, J., McCartney-Francis, N., & Chen, W. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1103539 · Cited by 172
Dual Role of Transforming Growth Factor β in Mammary Tumorigenesis and Metastatic Progression
Muraoka-Cook, R. S., Dumont, N., & Arteaga, C. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.937s.11.2 · Cited by 168
Lucas, C., Bald, L. N., Fendly, B. M., Mora-Worms, M., Figari, I. S., Patzer, E. J., & Palladino, M. A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.5.1415 · Cited by 164
Latent Transforming Growth Factor-β Activation in Mammary Gland
Ewan, K., Shyamala, G., Ravani, S. A., Tang, Y., Akhurst, R. J., Wakefield, L. M., & Barcellos‐Hoff, M. H. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61158-3 · Cited by 160
Muraoka-Cook, R. S., Kurokawa, H., Koh, Y., Forbes, J. T., Roebuck, L. R., Barcellos-Hoff, M. H., Moody, S. E., Chodosh, L. A., & Arteaga, C. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2111 · Cited by 159
Effects of TGF-β on the immune system: implications for cancer immunotherapy
de Visser, K., & Kast, W. M. (1999) · Leukemia · doi:10.1038/sj.leu.2401477 · Cited by 155
Zhang, Q., Yang, X. J., Pins, M., Javonovic, B., Kuzel, T. M., Kim, S., Parijs, L. V., Greenberg, N. M., Liu, V., Guo, Y., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3169 · Cited by 149
Modulation of the Immune Response by Transforming Growth Factor Beta
Fontana, A., Constam, D. B., Frei, K., Malipiero, U., & Pfister, H. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000236328 · Cited by 146
Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.
Bandyopadhyay, A. M., López‐Casillas, F., Malik, S. N., Montiel-Hernández, J. L., Mendoza, V., Yang, J., & Sun, L. (2002) · PubMed · Cited by 140
Muraoka-Cook, R. S., Shin, I., Yi, J. Y., Easterly, E., Barcellos‐Hoff, M. H., Yingling, J. M., Zent, R., & Arteaga, C. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208964 · Cited by 139
Cell-Type-Specific Activation of PAK2 by Transforming Growth Factor β Independent of Smad2 and Smad3
Wilkes, M. C., Murphy, S. J., Garamszegi, N., & Leof, E. B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8878-8889.2003 · Cited by 139
Arteaga, C. L., Dugger, T. C., Moses, H. L., Hurd, S. D., & Pietenpol, J. A. (1993) · PubMed · Cited by 139
Self-citationGilboa, L., Wells, R. G., Lodish, H. F., & Henis, Y. I. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.4.767 · Cited by 138
Subramanian, G., Schwarz, R. E., Higgins, L., McEnroe, G., Chakravarty, S., Dugar, S., & Reiss, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0018 · Cited by 138
Kang, S. H., Bang, Y., Im, Y., Yang, H.-K., Lee, D. A., Lee, H. Y., Lee, H. S., Kim, N. K., & Kim, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203146 · Cited by 136
Wang, X., Liefer, K. M., Tsai, S. Y., O’Malley, B. W., & Roop, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8483 · Cited by 135
Wang, X., Greenhalgh, D. A., Bickenbach, J. R., Jiang, A., Bundman, D. S., Krieg, T. M., Derynck, R., & Roop, D. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2386 · Cited by 135
Joseph, H., Gorska, A. E., Sohn, P., Moses, H. L., & Serra, R. A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.4.1221 · Cited by 132
Self-citationGorska, A. E., Jensen, R. A., Shyr, Y., Aakre, M. E., Bhowmick, N. A., & Moses, H. L. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63510-9 · Cited by 128
Self-citationLuo, K., & Lodish, H. F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00826.x · Cited by 124
Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.
Weeks, B. H., He, W., Olson, K. L., & Wang, X. J. (2001) · PubMed · Cited by 120
Amendt, C., Schirmacher, P., Weber, H., & Blessing, M. (1998) · Oncogene · doi:10.1038/sj.onc.1202161 · Cited by 119
The Soluble Exoplasmic Domain of the Type II Transforming Growth Factor (TGF)-β Receptor
Lin, H. Y.-F., Moustakas, A., Knaus, P. I., Wells, R. G., Henis, Y. I., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2747 · Cited by 117
Transforming growth factor-beta induces human T lymphocyte migration in vitro
Adams, D., Hathaway, M., Shaw, J., Burnett, D. A., Elias, E., & Strain, A. J. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.2.609 · Cited by 116
Ewan, K., Oketch‐Rabah, H. A., Ravani, S. A., Shyamala, G., Moses, H. L., & Barcellos‐Hoff, M. H. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62985-9 · Cited by 115
Self-citationBandyopadhyay, A. M., Zhu, Y., Cibull, M. L., Bao, L., Chen, C., & Sun, L. (1999) · PubMed · Cited by 115
Feng, X., & Derynck, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13123 · Cited by 106
Peng, S.-B., Yan, L., Xia, X., Watkins, S. A., Brooks, H. B., Beight, D. W., Herron, D. K., Jones, M. L., Lampe, J. W., McMillen, W. T., et al. (2005) · Biochemistry · doi:10.1021/bi048851x · Cited by 100
Essential Role for Smad3 in Regulating MCP-1 Expression and Vascular Inflammation
Feinberg, M. W., Shimizu, K., Lebedeva, M. A., Haspel, R. L., Takayama, K., Chen, Z., Frederick, J. P., Wang, X.-F., Simon, D. I., Libby, P., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000119170.70818.4f · Cited by 98
Kitamura, M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.3.1404 · Cited by 96
Cui, W., Fowlis, D. J., Cousins, F., Duffie, E., Bryson, S., Balmain, A., & Akhurst, R. J. (1995) · Genes & Development · doi:10.1101/gad.9.8.945 · Cited by 95
Reducing mammary cancer risk through premature stem cell senescence
Boulanger, C. A., & Smith, G. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204312 · Cited by 93
Desgrosellier, J. S., Mundell, N. A., McDonnell, M. A., Moses, H. L., & Barnett, J. V. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2004.12.037 · Cited by 92
Self-citationMa, D., & Niederkorn, J. Y. (1995) · PubMed Central · Cited by 84
Go, C., Li, P., & Wang, X. (1999) · PubMed · Cited by 79
Transforming growth factor‐β stimulates epithelial–mesenchymal transformation in the proepicardium
Olivey, H. E., Mundell, N. A., Austin, A. F., & Barnett, J. V. (2005) · Developmental Dynamics · doi:10.1002/dvdy.20593 · Cited by 78
Franitza, S., Kollet, Ó., Brill, A. G., Vaday, G. G., Petit, I., Lapidot, T., Alon, R., & Lider, O. (2002) · European Journal of Immunology · Cited by 78
Schlingensiepen, R., Goldbrunner, M., Szyrach, M., Stauder, G., Jachimczak, P., Bogdahn, U., Schulmeyer, F. J., Hau, P., & Schlingensiepen, K. (2005) · Oligonucleotides · doi:10.1089/oli.2005.15.94 · Cited by 69
Pangas, S. A., & Matzuk, M. M. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.02.017 · Cited by 69
Activin receptor-like kinase 2 can mediate atrioventricular cushion transformation.
Lai, Y.-T., Beason, K., Brames, G. P., Desgrosellier, J. S., Clegett, M. C., Shaw, M. V., Brown, C. B., & Barnett, J. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9698 · Cited by 64
Landis, M. D., Seachrist, D. D., Montanez-Wiscovich, M. E., Danielpour, D., & Keri, R. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208712 · Cited by 58
Giannouli, C., & Kletsas, D. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.11.002 · Cited by 57
Smad7 is required for TGF-β-induced activation of the small GTPase Cdc42
Edlund, S., Landström, M., Heldin, C., & Aspenström, P. (2004) · Journal of Cell Science · doi:10.1242/jcs.01036 · Cited by 57
Johns, L. D., Babcock, G., Green, D., Freedman, M. S., Sriram, S., & Ransohoff, R. M. (1992) · Brain Research · doi:10.1016/0006-8993(92)91211-v · Cited by 56
Fowlis, D. J., Cui, W., Johnson, S. A., Balmain, A., & Akhurst, R. J. (1996) · PubMed · Cited by 55
Ruzek, M. C., Hawes, M. L., Pratt, B. M., McPherson, J. M., Ledbetter, S., Richards, S. M., & Garman, R. D. (2003) · Immunopharmacology and Immunotoxicology · doi:10.1081/iph-120020473 · Cited by 52
Chiu, C., Maddock, D. A., Zhang, Q., Souza, K. P., Townsend, A. R., & Wan, Y. (2001) · International Journal of Molecular Medicine · doi:10.3892/ijmm.8.3.251 · Cited by 51
Clinical significance of the expression of activin A in esophageal carcinoma
Yoshinaga, K., Mimori, K., Yamashita, K., Utsunomiya, T., Inoue, H., & Mori, M. (2003) · International Journal of Oncology · doi:10.3892/ijo.22.1.75 · Cited by 48
A fully human antibody neutralising biologically active human TGFβ2 for use in therapy
Thompson, J. E., Vaughan, T. J., Williams, A. J., Wilton, J., Johnson, K. S., Bacon, L., Green, J. A., Field, R. P., Ruddock, S., MARTINS, M. S., et al. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00060-5 · Cited by 44
TGF‐beta inhibits proliferation of and promotes differentiation of human promonocytic leukemia cells
Bombara, C., & Ignotz, R. A. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041530106 · Cited by 41
Selective inhibitors of type I receptor kinase block cellular transforming growth factor-β signaling
Ge, R., Rajeev, V., Subramanian, G., Reiss, K. A., Liu, D., Higgins, L. S., Joly, A. H., Dugar, S., Chakravarty, J., Henson, M., et al. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.03.011 · Cited by 40
Expression of TGF‐β2 in Human Glioblastoma: A Role in Resistance to Immune Rejection?
Fontana, A., Bodmer, S., Frei, K., Malipiero, U., & Siepl, C. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514061.ch15 · Cited by 36
Witham, T. F., Villa, L., Yang, T., Pollack, I. F., Okada, H., Robbins, P. D., & Chambers, W. H. (2003) · Journal of Neuro-Oncology · doi:10.1007/bf02700021 · Cited by 26
Arteaga, C. L., Dugger, T. C., Winnier, A. R., & Forbes, J. T. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240531134 · Cited by 26
Cited by
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
Metadata
- Authors
- Bierie, B., & Moses, H. L.
- Venue
- Nature Reviews Cancer
- Published
- 2006-07
- Volume
- 6
- Issue
- 7
- Pages
- 506-520
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1984162437
- Cited by
- 1,267
- References
- 155
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.